Free Trial

Sidoti Csr Issues Pessimistic Outlook for TrueBlue Earnings

TrueBlue logo with Business Services background

Key Points

  • Sidoti Csr has revised TrueBlue's Q3 2025 earnings per share estimate to ($0.09), significantly down from the prior forecast of $0.04, reflecting a pessimistic outlook.
  • BMO Capital Markets has increased its price target on TrueBlue from $7.00 to $8.00 and rated the company as "outperform."
  • TrueBlue’s share price has decreased by 3.1%, currently trading around $5.90, amidst concerns about profitability and earnings performance.
  • Looking to Export and Analyze TrueBlue Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

TrueBlue, Inc. (NYSE:TBI - Free Report) - Sidoti Csr cut their Q3 2025 EPS estimates for shares of TrueBlue in a report released on Tuesday, August 5th. Sidoti Csr analyst M. Riddick now anticipates that the business services provider will post earnings per share of ($0.09) for the quarter, down from their previous forecast of $0.04. The consensus estimate for TrueBlue's current full-year earnings is $0.15 per share. Sidoti Csr also issued estimates for TrueBlue's Q4 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.57) EPS.

Separately, BMO Capital Markets lifted their price objective on TrueBlue from $7.00 to $8.00 and gave the company an "outperform" rating in a research report on Wednesday.

Get Our Latest Stock Report on TBI

TrueBlue Stock Down 3.1%

NYSE TBI opened at $5.90 on Thursday. The firm has a market cap of $176.53 million, a PE ratio of -5.13 and a beta of 1.55. TrueBlue has a one year low of $3.45 and a one year high of $9.05. The stock's 50 day simple moving average is $6.63 and its 200 day simple moving average is $6.10. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.94 and a quick ratio of 1.80.

TrueBlue (NYSE:TBI - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The business services provider reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.31) by $0.24. TrueBlue had a negative net margin of 2.21% and a negative return on equity of 5.74%. The company had revenue of $396.30 million during the quarter, compared to analyst estimates of $400.52 million.

Institutional Investors Weigh In On TrueBlue

A number of hedge funds have recently added to or reduced their stakes in the stock. Peapod Lane Capital LLC acquired a new position in shares of TrueBlue during the first quarter worth approximately $1,385,000. GSA Capital Partners LLP lifted its holdings in TrueBlue by 527.3% during the 1st quarter. GSA Capital Partners LLP now owns 287,625 shares of the business services provider's stock worth $1,527,000 after buying an additional 241,777 shares in the last quarter. Bank of America Corp DE lifted its holdings in TrueBlue by 143.0% during the 4th quarter. Bank of America Corp DE now owns 77,327 shares of the business services provider's stock worth $650,000 after buying an additional 45,509 shares in the last quarter. Pzena Investment Management LLC boosted its position in TrueBlue by 1.7% in the 1st quarter. Pzena Investment Management LLC now owns 2,835,167 shares of the business services provider's stock valued at $15,055,000 after buying an additional 46,539 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of TrueBlue in the 4th quarter valued at $478,000. Institutional investors own 97.15% of the company's stock.

About TrueBlue

(Get Free Report)

TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.

Recommended Stories

Earnings History and Estimates for TrueBlue (NYSE:TBI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in TrueBlue Right Now?

Before you consider TrueBlue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TrueBlue wasn't on the list.

While TrueBlue currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines